Antao Xu

Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Efficacy and safety of ruxolitinib in adult patients with refractory rheumatic disease-associated macrophage activation syndrome.

Efficacy and safety of ruxolitinib in adult patients with refractory rheumatic disease-associated macrophage activation syndrome.

Journal: Frontiers in immunology
Published: April 02, 2025

Efficacy and safety of jaktinib hydrochloride tablets in active axial spondyloarthritis: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial.

Efficacy and safety of jaktinib hydrochloride tablets in active axial spondyloarthritis: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial.

Journal: RMD open
Published: August 13, 2024

Anti-synthetase syndrome is associated with a higher risk of hospitalization among patients with idiopathic inflammatory myopathy and COVID-19.

Anti-synthetase syndrome is associated with a higher risk of hospitalization among patients with idiopathic inflammatory myopathy and COVID-19.

Journal: Frontiers in immunology
Published: September 16, 2023

Ruxolitinib rescued the macrophage activation syndrome in adult-onset Still's disease with delayed hypersensitivity reaction to tocilizumab.

Ruxolitinib rescued the macrophage activation syndrome in adult-onset Still's disease with delayed hypersensitivity reaction to tocilizumab.

Journal: Rheumatology (Oxford, England)
Published: December 06, 2022

Pneumomediastinum and Subcutaneous Facial Emphysema in Antimelanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis.

Pneumomediastinum and Subcutaneous Facial Emphysema in Antimelanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis.

Journal: The Journal of rheumatology
Published: September 15, 2022

Cutaneous ulceration and digital gangrene in an anti-MDA5-positive overlap myositis.

Cutaneous ulceration and digital gangrene in an anti-MDA5-positive overlap myositis.

Journal: Rheumatology (Oxford, England)
Published: December 22, 2020

Long noncoding RNA TCONS_00026334 is involved in suppressing the progression of colorectal cancer by regulating miR-548n/TP53INP1 signaling pathway.

Long noncoding RNA TCONS_00026334 is involved in suppressing the progression of colorectal cancer by regulating miR-548n/TP53INP1 signaling pathway.

Journal: Cancer medicine
Published: July 06, 2020

Prognostic values of anti-Ro52 antibodies in anti-MDA5-positive clinically amyopathic dermatomyositis associated with interstitial lung disease.

Prognostic values of anti-Ro52 antibodies in anti-MDA5-positive clinically amyopathic dermatomyositis associated with interstitial lung disease.

Journal: Rheumatology (Oxford, England)
Published: May 15, 2020

Roles of PD-1/PD-L1 Pathway: Signaling, Cancer, and Beyond.

Roles of PD-1/PD-L1 Pathway: Signaling, Cancer, and Beyond.

Journal: Advances in experimental medicine and biology
Published: March 19, 2020

Synbindin restrains proinflammatory macrophage activation against microbiota and mucosal inflammation during colitis.

Synbindin restrains proinflammatory macrophage activation against microbiota and mucosal inflammation during colitis.

Journal: Gut
Published: March 11, 2020

Synbindin deficiency inhibits colon carcinogenesis by attenuating Wnt cascade and balancing gut microbiome.

Synbindin deficiency inhibits colon carcinogenesis by attenuating Wnt cascade and balancing gut microbiome.

Journal: International journal of cancer
Published: July 18, 2018

Low-dose penicillin exposure in early life decreases Th17 and the susceptibility to DSS colitis in mice through gut microbiota modification.

Low-dose penicillin exposure in early life decreases Th17 and the susceptibility to DSS colitis in mice through gut microbiota modification.

Journal: Scientific reports
Published: October 18, 2016
Showing 1-12 of 16

Last Updated: 09/26/2026